RLX Technology

RLXNYSE Cayman Islands Health Care Medicinal Chemicals and Botanical Products

Market cap

$3.113 B

$2.01 +1.00%

Close of 7 Aug 2026

Revenue

$566.1M

#1850 by revenue

Earnings

$131.8M

#1194 by earnings

Shares outstanding

1,548,940,307

Latest filing cover page

P/E ratio

23.6

Cap ÷ net income

Medicinal Chemicals and Botanical Products — ranked by market cap

All 26 →

#3Altria GroupMO$114.1B
#4Definium TherapeuticsDFTX$5.03B
#5RLX TechnologyRLX$3.11B
#6Regencell BioscienceRGC$2.68B
#7Trulieve CannabisTRLV$1.68B

Where these numbers come from

Share counts and financials for RLX Technology are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.